Details
'Best Practices for Screening, Diagnosing and Treating Transthyretin Amyloid Cardiomyopathy (ATTR-CM)'
check back for how to receive CME credit for viewing this program *
In this symposium, cardiac amyloidosis experts (Dr. Ahmad Masri, Dr. Ronald Witteles and Dr. Marcus Urey) will identify red flags that should raise suspicion for ATTR-CM and explain a practical algorithm to make an accurate and early diagnosis. Best use of guideline-recommended medical therapy (GDMT) for HF in ATTR-CM will be described, and clinical evidence with disease-modifying ATTR-CM therapies interpreted. A case-based discussion on optimal management of ATTR-CM will address issues related to recognition, diagnosis, and treatment.